首页|hPSC源少突胶质前体细胞用于脊髓损伤的治疗作用

hPSC源少突胶质前体细胞用于脊髓损伤的治疗作用

扫码查看
脊髓损伤(spinal cord injury,SCI)是一种严重的中枢神经系统(central nervous system,CNS)疾病,常导致严重的功能障碍,因其病理生理机制尚不完全清楚,仍为世界性的医学难题.随着对少突胶质前体细胞(oligodendrocyte progenitor cell,OPC)在CNS中作用的深入研究,以此为基础的细胞疗法成为一种有最具前景的治疗策略.动物实验结果表明,OPC移植到损伤脊髓可促进髓鞘再生、改善运动功能.该文介绍了关于OPC治疗SCI的基本情况,总结了已有的研究成果,指出了其在临床应用中面临的挑战,从而为进一步研究和开发有效的治疗策略提供了依据.
The Therapeutic Effect of hPSC Derived Oligodendrocyte Precursor Cells on Spinal Cord Injury
SCI(spinal cord injury)is a devastating CNS(central nervous system)disorder that often results in severe functional impairments.Due to the incomplete understanding of its underlying pathophysiological mecha-nisms,SCI remains a global medical challenge.In recent years,the in-depth understanding of the role of OPC(oligodendrocyte progenitor cell)in the CNS has led to the emergence of cell therapy as a promising strategy.Ex-tensive animal experiments have shown that OPC transplantation into injured spinal cord promotes remyelination and significantly improves motor function.This review provides a foundation of knowledge regarding OPC-based treatment for SCI,summarizes the existing research findings,and identifies the challenges encountered in clinical applications.It serves as a basis for further research and development of effective therapeutic strategies.

oligodendrocyte precursor cellspinal cord injuryclinical trialdemyelinationremyelination

潘辉、鲍莉、纪猛、张锋、吴月红

展开 >

浙江理工大学,生命科学与医药学院,杭州 310018

浙江泉生生物工程有限公司,研发部,杭州 310018

霍尔果斯新生泉干细胞医疗有限公司,研发部,伊犁哈萨克自治州 835221

少突胶质前体细胞 脊髓损伤 临床试验 脱髓鞘 髓鞘再生

伊犁哈萨克自治州科学技术计划伊犁哈萨克自治州科学技术计划

YKX2023A11YKX2024A01

2024

中国细胞生物学学报
中国科学院上海生命科学研究院,生物化学与细胞生物学研究所,中国细胞生物学学会

中国细胞生物学学报

CSTPCD
影响因子:0.554
ISSN:1674-7666
年,卷(期):2024.46(8)